Allergen immunotherapy (AIT) also known as desensitisation, uniquely alters the natural course of respiratory allergies.
AIT is the only therapeutic class capable of modifying the disease progression and potentially preventing the onset of the disease by inducing tolerance in the immune system (source: Global Atlas of Allergy, EAACI 2014).
As part of our commitment to help patients live life beyond allergy, we offer a broad portfolio of allergen extracts and a wide range of state-of-the-art therapeutic solutions for children and adults which provide long lasting relief from the burden of allergies.
Spanning source materials, routes of administration, cutting-edge delivery mechanisms and finished products, ours is an innovative portfolio of therapeutic solutions designed to improve ease of access and treatment outcomes*.
Whatever the options, all of our AIT treatments meet the most stringent clinical criteria as well as health authorities’ regulatory requirements.
*not all products are manufactured in all regions
Stallergenes Greer's manufacturing facilities in Lenoir, NC, USA